Your browser doesn't support javascript.
loading
Whole-exome sequencing of 81 individuals from 27 multiply affected bipolar disorder families.
Forstner, Andreas J; Fischer, Sascha B; Schenk, Lorena M; Strohmaier, Jana; Maaser-Hecker, Anna; Reinbold, Céline S; Sivalingam, Sugirthan; Hecker, Julian; Streit, Fabian; Degenhardt, Franziska; Witt, Stephanie H; Schumacher, Johannes; Thiele, Holger; Nürnberg, Peter; Guzman-Parra, José; Orozco Diaz, Guillermo; Auburger, Georg; Albus, Margot; Borrmann-Hassenbach, Margitta; González, Maria José; Gil Flores, Susana; Cabaleiro Fabeiro, Francisco J; Del Río Noriega, Francisco; Perez Perez, Fermin; Haro González, Jesus; Rivas, Fabio; Mayoral, Fermin; Bauer, Michael; Pfennig, Andrea; Reif, Andreas; Herms, Stefan; Hoffmann, Per; Pirooznia, Mehdi; Goes, Fernando S; Rietschel, Marcella; Nöthen, Markus M; Cichon, Sven.
Afiliação
  • Forstner AJ; Centre for Human Genetics, University of Marburg, Marburg, Germany. andreas.forstner@uni-marburg.de.
  • Fischer SB; Institute of Human Genetics, University of Bonn, School of Medicine & University Hospital Bonn, Bonn, Germany. andreas.forstner@uni-marburg.de.
  • Schenk LM; Department of Biomedicine, University of Basel, Basel, Switzerland. andreas.forstner@uni-marburg.de.
  • Strohmaier J; Department of Psychiatry (UPK), University of Basel, Basel, Switzerland. andreas.forstner@uni-marburg.de.
  • Maaser-Hecker A; Department of Biomedicine, University of Basel, Basel, Switzerland.
  • Reinbold CS; Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland.
  • Sivalingam S; Institute of Human Genetics, University of Bonn, School of Medicine & University Hospital Bonn, Bonn, Germany.
  • Hecker J; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
  • Streit F; SRH University Heidelberg, Academy for Psychotherapy, Heidelberg, Germany.
  • Degenhardt F; Institute of Human Genetics, University of Bonn, School of Medicine & University Hospital Bonn, Bonn, Germany.
  • Witt SH; Department of Biomedicine, University of Basel, Basel, Switzerland.
  • Schumacher J; Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland.
  • Thiele H; Center for Lifespan Changes in Brain and Cognition (LCBC), Department of Psychology, University of Oslo, Oslo, Norway.
  • Nürnberg P; Institute of Human Genetics, University of Bonn, School of Medicine & University Hospital Bonn, Bonn, Germany.
  • Guzman-Parra J; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
  • Orozco Diaz G; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
  • Auburger G; Institute of Human Genetics, University of Bonn, School of Medicine & University Hospital Bonn, Bonn, Germany.
  • Albus M; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
  • Borrmann-Hassenbach M; Centre for Human Genetics, University of Marburg, Marburg, Germany.
  • González MJ; Institute of Human Genetics, University of Bonn, School of Medicine & University Hospital Bonn, Bonn, Germany.
  • Gil Flores S; Cologne Center for Genomics, University of Cologne, Cologne, Germany.
  • Cabaleiro Fabeiro FJ; Cologne Center for Genomics, University of Cologne, Cologne, Germany.
  • Del Río Noriega F; Department of Mental Health, University Regional Hospital of Málaga, Institute of Biomedicine of Málaga (IBIMA), Málaga, Spain.
  • Perez Perez F; Unidad de Gestión Clínica del Dispositivo de Cuidados Críticos y Urgencias del Distrito Sanitario Málaga - Coin-Gudalhorce, Málaga, Spain.
  • Haro González J; Experimental Neurology, Department of Neurology, Goethe University Hospital, Frankfurt am Main, Germany.
  • Rivas F; Isar Amper Klinikum München Ost, kbo, Haar, Germany.
  • Mayoral F; Isar Amper Klinikum München Ost, kbo, Haar, Germany.
  • Bauer M; Department of Mental Health, University Regional Hospital of Málaga, Institute of Biomedicine of Málaga (IBIMA), Málaga, Spain.
  • Pfennig A; Department of Mental Health, University Hospital of Reina Sofia, Cordoba, Spain.
  • Reif A; Department of Mental Health, Hospital of Jaén, Jaén, Spain.
  • Herms S; Department of Mental Health, Hospital of Jerez de la Frontera, Jerez de la Frontera, Spain.
  • Hoffmann P; Department of Mental Health, Hospital of Puerto Real, Cádiz, Spain.
  • Pirooznia M; Department of Mental Health, Hospital Punta de Europa, Algeciras, Spain.
  • Goes FS; Department of Psychiatry, Carlos Haya Regional University Hospital, Malaga, Spain.
  • Rietschel M; Department of Psychiatry, Carlos Haya Regional University Hospital, Malaga, Spain.
  • Nöthen MM; Department of Psychiatry and Psychotherapy, Medical Faculty, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Cichon S; Department of Psychiatry and Psychotherapy, Medical Faculty, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
Transl Psychiatry ; 10(1): 57, 2020 02 04.
Article em En | MEDLINE | ID: mdl-32066727
ABSTRACT
Bipolar disorder (BD) is a highly heritable neuropsychiatric disease characterized by recurrent episodes of depression and mania. Research suggests that the cumulative impact of common alleles explains 25-38% of phenotypic variance, and that rare variants may contribute to BD susceptibility. To identify rare, high-penetrance susceptibility variants for BD, whole-exome sequencing (WES) was performed in three affected individuals from each of 27 multiply affected families from Spain and Germany. WES identified 378 rare, non-synonymous, and potentially functional variants. These spanned 368 genes, and were carried by all three affected members in at least one family. Eight of the 368 genes harbored rare variants that were implicated in at least two independent families. In an extended segregation analysis involving additional family members, five of these eight genes harbored variants showing full or nearly full cosegregation with BD. These included the brain-expressed genes RGS12 and NCKAP5, which were considered the most promising BD candidates on the basis of independent evidence. Gene enrichment analysis for all 368 genes revealed significant enrichment for four pathways, including genes reported in de novo studies of autism (padj < 0.006) and schizophrenia (padj = 0.015). These results suggest a possible genetic overlap with BD for autism and schizophrenia at the rare-sequence-variant level. The present study implicates novel candidate genes for BD development, and may contribute to an improved understanding of the biological basis of this common and often devastating disease.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtorno Bipolar / Proteínas RGS Limite: Humans País como assunto: Europa Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtorno Bipolar / Proteínas RGS Limite: Humans País como assunto: Europa Idioma: En Ano de publicação: 2020 Tipo de documento: Article